Dr. Summer Dewdney & John McIlwain explore pharmaceutical efforts to increase diversity in clinical trials with Neha Shah Londono, formerly from Seagen, now Pfizer. Ms. Londono emphasized that the pharmaceutical industry is very focused on improving diversity in clinical trials to insure that the data coming out of trials truly reflects the health needs of the world's population.